Astrazeneca reported a 44% stake in Cellectis CLLS · 44,000,000 sh · amendment

Trade details

Type: 5% stake report
Report: 13D · amendment
Stake: 44%
Last report: No earlier report
Shares held: 44,000,000 sh
Class: Ordinary shares, nominal value of EUR0.05 per ordinary share
Stock: Cellectis CLLS
Holder: Astrazeneca
Event date: 25/01/23
Filed: 25/01/24

44% stake

Cellectis trades, last 26 weeks

What else happened in Cellectis around then

Filed or reported within 30 days of the trade day · 24/12/24~25/02/22

Astrazeneca's other 5% stake reports

Astrazeneca
5% stakeInnate Pharma
5% stake
Innate Pharma
IPHA
8.3% stake
7,825,501 sh
8.3% stake
Filed 02/06

Astrazeneca reported a 44% stake in Cellectis CLLS · 44,000,000 sh · amendment | Whalegun